ALKERMES | ALKS - Trade Creditors

Stock Price
34.78
Daily Change
-0.18 -0.51%
Monthly
24.21%
Yearly
13.07%
Q1 Forecast
32.88

ALKERMES reported $68M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 32.25B 1.2B Jun/2025
Acadia Pharmaceuticals USD 21.75M 1.65M Sep/2025
ALKERMES USD 68M 31.21M Sep/2025
Amgen USD 19.64B 1.61B Sep/2025
Biogen USD 413.1M 4.7M Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
J&J USD 9.62B 161M Sep/2025
Malin Corporation EUR 700K 200K Dec/2024
Merck USD 4.15B 102M Sep/2025
Neurocrine Biosciences USD 119.9M 15.3M Sep/2025
Otsuka Holdings JPY 194.02B 15.82B Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Vertex Pharmaceuticals USD 4.03B 320.8M Sep/2025